Skip to main content
Clobetasol promotes remyelination in a mouse model of neuromyelitis optica.
Published Web Location
http://europepmc.org/articles/PMC4845317?pdf=renderNo data is associated with this publication.
Abstract
Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system that can produce marked neurological deficit. Current NMO therapies include immunosuppressants, plasma exchange and B-cell depletion. Here, we evaluated 14 po
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.